News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
09
2024
-
01
Technology pilot, another award | warm congratulations to linuo pharmaceutical was awarded the Jinan enterprise technology center in 2023!
Classification：
News
Corporate News
Technical Navigator-Reawarded
Recently, the Jinan Municipal Bureau of Industry and Information Technology announced the municipal level in 2023.Enterprise Technology CenterAssessment results,Shandong Linuo Pharmaceutical Co., Ltd. Glory on the List!
Enterprise Technology Center inTechnology R & D and innovation demonstrationIt has a high threshold. The enterprises that have been evaluated should have strongTechnological innovation ability, market competitiveness, economic benefits and development potentialIt can undertake research projects of national, local and other enterprises, and carry out technology development and service work.
lino pharmaceutical insistLeading high-quality development with technological innovationWe will continue to tackle cutting-edge issues and actively explore the niche areas of chronic disease characteristicsDriven by technology research and development, intelligent manufacturing and cultural marketingEscort development with science and technology, and create brilliance with strength.
Jinan Enterprise Technology Center, isMilestone on the road to strong pharmaceutical technologyYes, to the company.Recognition of technical strengthAnd even more right.Incentives for the future development of enterprises. In the future, the company will continue to increase its investment in technological innovation and research and development,Demonstrate the power of example, continue to output accurate lino solutions for the healthy China cause.
Last article
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China